Acticor Biotech SAS-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Acticor Biotech SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011866
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Acticor Biotech SAS (Acticor), a subsidiary of MabDesign is a biopharmaceutical company that develops innovative therapeutic strategy for the emergency treatment of ischemic strokes. The company provides Fab product that provides monoclonal antibody targeting solutions through platelet glycoprotein VI, which is a protein cloned in the INSERM unit U1148. Its Fab finds application in the area of antithrombic treatments and that is suitable for even to treat thrombolysis patients. The company’s products are used through stems from sheer need for new therapeutic options to manage stroke. It markets its products through its network of distributors in France. Acticor is headquartered in Paris, France.

Acticor Biotech SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Acticor Biotech SAS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
Acticor Biotech Raises Additional USD1.6 Million in Venture Financing 9
Acticor Biotech Raises USD1.6 Million in Venture Financing 10
Acticor Biotech Raises USD0.7 Million in Seed Financing 11
Partnerships 12
Acticor Biotech Enters into Research Agreement with Mediolanum farmaceutici 12
Acticor Biotech Enters into Agreement with Catalent 13
Licensing Agreements 14
Acticor Biotech Enters into Licensing Agreement with Inserm Transfert 14
Acticor Biotech SAS – Key Competitors 15
Acticor Biotech SAS – Key Employees 16
Acticor Biotech SAS – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Clinical Trials 18
Feb 23, 2017: Acticor Biotech Has Selected Its Contract Research Organisation to Manage Clinical Study Phase I 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Key Facts 2
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Acticor Biotech SAS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Acticor Biotech SAS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Acticor Biotech Raises Additional USD1.6 Million in Venture Financing 9
Acticor Biotech Raises USD1.6 Million in Venture Financing 10
Acticor Biotech Raises USD0.7 Million in Seed Financing 11
Acticor Biotech Enters into Research Agreement with Mediolanum farmaceutici 12
Acticor Biotech Enters into Agreement with Catalent 13
Acticor Biotech Enters into Licensing Agreement with Inserm Transfert 14
Acticor Biotech SAS, Key Competitors 15
Acticor Biotech SAS, Key Employees 16
Acticor Biotech SAS, Other Locations 17

★海外企業調査レポート[Acticor Biotech SAS-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vigo Coal Company Incorporated:企業の戦略・SWOT・財務情報
    Vigo Coal Company Incorporated - Strategy, SWOT and Corporate Finance Report Summary Vigo Coal Company Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Seikagaku Corp (4548):企業の財務・戦略的SWOT分析
    Summary Seikagaku Corp (Seikagaku) is a manufacturer and supplier of pharmaceuticals and medical devices. The company offers products such as pharmaceuticals and medical devices, bulk products, endotoxin-detecting reagents and oral care products. It also manufactures and markets pharmaceutical produ …
  • Cadence Bancorporation (CADE):企業の財務・戦略的SWOT分析
    Cadence Bancorporation (CADE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Enusa Industrias Avanzadas, S.A., S.M.E:企業の戦略的SWOT分析
    Enusa Industrias Avanzadas, S.A., S.M.E - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Best Western International Inc:企業の戦略・SWOT・財務情報
    Best Western International Inc - Strategy, SWOT and Corporate Finance Report Summary Best Western International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • KMG Chemicals Inc (KMG):企業の財務・戦略的SWOT分析
    KMG Chemicals Inc (KMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Snap-on Incorporated:戦略・SWOT・企業財務分析
    Snap-on Incorporated - Strategy, SWOT and Corporate Finance Report Summary Snap-on Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Atlas Genetics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposab …
  • Kina Petroleum Ltd (KPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Kina Petroleum Limited (KPL) is an upstream oil and gas company that focuses on exploration, development and production activities. It has operations in Papua New Guinea (PNG) and Australia. The company focuses on participating in highly prospective oil and gas acreage positions near to prov …
  • Ei Group plc:企業の戦略・SWOT・財務情報
    Ei Group plc - Strategy, SWOT and Corporate Finance Report Summary Ei Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Dynavax Technologies Corp (DVAX):企業の財務・戦略的SWOT分析
    Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • SLEEP NUMBER CORP:企業の戦略・SWOT・財務情報
    SLEEP NUMBER CORP - Strategy, SWOT and Corporate Finance Report Summary SLEEP NUMBER CORP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Nihon Kohden Corp (6849)-医療機器分野:企業M&A・提携分析
    Summary Nihon Kohden Corp (Nihon Kohden) is a provider of medical electronic equipment to support treatment in clinical areas of emergency response; testing, diagnosis, treatment, and rehabilitation. Its major products include patient monitors, electroencephalographs, evoked potential and electromyo …
  • Nirulas Corner House Private Limited:企業の戦略・SWOT・財務情報
    Nirulas Corner House Private Limited - Strategy, SWOT and Corporate Finance Report Summary Nirulas Corner House Private Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Trina Solar Co Ltd (688599):企業の財務・戦略的SWOT分析
    Trina Solar Co Ltd (688599) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Interface Biologics Inc:製品パイプライン分析
    Summary Interface Biologics Inc (IBI) is a developer transformative biomedical polymer technology. The company offers anti-thrombogenic and combination drug delivery devices. Its blood contacting medical devices uses Endexo technology address problems related to thrombosis. IBI’s technologies includ …
  • Dusit Thani Public Company Limited:企業の戦略・SWOT・財務情報
    Dusit Thani Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Dusit Thani Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Unilife Corporation (UNIS)-医療機器分野:企業M&A・提携分析
    Summary Unilife Corporation (Unilife) is a developer and commercial supplier of injectable drug delivery systems with focus on wearable injector products. It develops, manufactures and distributes safety engineered syringes for medical device and pharmaceutical industries. The company's product port …
  • Securitas AB:企業の戦略・SWOT・財務分析
    Securitas AB - Strategy, SWOT and Corporate Finance Report Summary Securitas AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Cardinal Ethanol LLC (CRDE):企業の戦略的SWOT分析
    Cardinal Ethanol LLC (CRDE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆